180 related articles for article (PubMed ID: 32867714)
1. Prophylactic chemotherapeutic hyperthermic intraperitoneal perfusion reduces peritoneal metastasis in gastric cancer: a retrospective clinical study.
Zhu L; Xu Z; Wu Y; Liu P; Qian J; Yu S; Xia B; Lai J; Ma S; Wu Z
BMC Cancer; 2020 Aug; 20(1):827. PubMed ID: 32867714
[TBL] [Abstract][Full Text] [Related]
2. The role of prophylactic hyperthermic intraperitoneal chemotherapy in the management of serosal involved gastric cancer.
Saladino E; Fleres F; Mazzeo C; Pruiti V; Scollica M; Rossitto M; Cucinotta E; Macrì A
Anticancer Res; 2014 Apr; 34(4):2019-22. PubMed ID: 24692741
[TBL] [Abstract][Full Text] [Related]
3. Hyperthermic intraperitoneal chemotherapy plus simultaneous versus staged cytoreductive surgery for gastric cancer with occult peritoneal metastasis.
Wu X; Li Z; Li Z; Jia Y; Shan F; Ji X; Bu Z; Zhang L; Wu A; Ji J
J Surg Oncol; 2015 Jun; 111(7):840-7. PubMed ID: 25864884
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy of type-B ultrasound-guided intraperitoneal hyperthermic chemoperfusion combined with systemic chemotherapy in advanced gastric cancer patients with malignant ascites.
Lu C; Li L; Luo Z; Cui Y; Fu P; Zhou J; Ma N; Zhou Y
Neoplasma; 2016; 63(2):299-303. PubMed ID: 26774152
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic hyperthermic intraperitoneal chemotherapy for patients with clinical T4 gastric cancer.
Lee TY; Hsu CH; Fan HL; Liao GS; Chen TW; Chan DC
Eur J Surg Oncol; 2022 Sep; 48(9):1972-1979. PubMed ID: 35508455
[TBL] [Abstract][Full Text] [Related]
6. Tumor characteristics and clinical outcome of peritoneal metastasis of gastric origin treated with a hyperthermic intraperitoneal chemotherapy procedure in the PERISCOPE I trial.
Koemans WJ; van der Kaaij RT; Wassenaar ECE; Boerma D; Boot H; Sikorska K; Los M; Grootscholten C; Hartemink KJ; Veenhof AAFA; Kodach L; Snaebjornsson P; van Sandick JW
J Surg Oncol; 2021 Mar; 123(4):904-910. PubMed ID: 33428786
[TBL] [Abstract][Full Text] [Related]
7. Intraperitoneal perfusion chemotherapy and whole abdominal hyperthermia using external radiofrequency following radical D2 resection for treatment of advanced gastric cancer.
Zhu L; Xu Y; Shan Y; Zheng R; Wu Z; Ma S
Int J Hyperthermia; 2019; 36(1):403-407. PubMed ID: 30829551
[TBL] [Abstract][Full Text] [Related]
8. Preliminary results of prophylactic HIPEC in patients with locally advanced gastric cancer.
Graziosi L; Cantarella F; Mingrone E; Gunnellini M; Cavazzoni E; Liberati M; Donini A
Ann Ital Chir; 2013; 84(5):551-6. PubMed ID: 24140896
[TBL] [Abstract][Full Text] [Related]
9. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Carcinomatosis: Multicenter Study of Spanish Group of Peritoneal Oncologic Surgery (GECOP).
Manzanedo I; Pereira F; Rihuete Caro C; Pérez-Viejo E; Serrano Á; Gutiérrez Calvo A; Regueira FM; Casado-Adam Á; Cascales-Campos PA; Arteaga X; García-Fadrique A; Gómez Sanz R; López García A; Zozaya G; Arjona Á; Gil Martínez J
Ann Surg Oncol; 2019 Aug; 26(8):2615-2621. PubMed ID: 31115852
[TBL] [Abstract][Full Text] [Related]
10. [Progress in conversion therapy for stage IV gastric cancer].
Liang H
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):107-111. PubMed ID: 33508914
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Postoperative Chemotherapy After Resection that Leaves No Macroscopically Visible Disease of Gastric Cancer with Positive Peritoneal Lavage Cytology (CY1) or Localized Peritoneum Metastasis (P1a): A Multicenter Retrospective Study.
Yamaguchi T; Takashima A; Nagashima K; Makuuchi R; Aizawa M; Ohashi M; Tashiro K; Yamada T; Kinoshita T; Hata H; Kawachi Y; Kawabata R; Tsuji T; Hihara J; Sakamoto T; Fukagawa T; Katai H; Higuchi K; Boku N
Ann Surg Oncol; 2020 Jan; 27(1):284-292. PubMed ID: 31535301
[TBL] [Abstract][Full Text] [Related]
12. Peritoneal Involvement Is More Common Than Nodal Involvement in Patients With High-Grade Appendix Tumors Who Are Undergoing Prophylactic Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Mehta A; Mittal R; Chandrakumaran K; Carr N; Dayal S; Mohamed F; Moran B; Cecil T
Dis Colon Rectum; 2017 Nov; 60(11):1155-1161. PubMed ID: 28991079
[TBL] [Abstract][Full Text] [Related]
13. A controlled clinical study of serosa-invasive gastric carcinoma patients who underwent surgery plus intraperitoneal hyperthermo-chemo-perfusion (IHCP).
Kim JY; Bae HS
Gastric Cancer; 2001; 4(1):27-33. PubMed ID: 11706624
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of TCM therapies combined with hyperthermic intraperitoneal chemotherapy for peritoneal metastasis of gastric cancer: A protocol for systematic review and meta-analysis.
Zhu X; Wu Z; Cao Y; Gao R; Zhang X; Li J
Medicine (Baltimore); 2021 Jan; 100(4):e24337. PubMed ID: 33530226
[TBL] [Abstract][Full Text] [Related]
15. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel to treat synchronous peritoneal carcinomatosis from gastric cancer: Results from a Chinese center.
Wu HT; Peng KW; Ji ZH; Sun JH; Zhang Q; Yang XJ; Huang CQ; Li Y
Eur J Surg Oncol; 2016 Jul; 42(7):1024-34. PubMed ID: 27179924
[TBL] [Abstract][Full Text] [Related]
16. Downstaging of lymph node metastasis after neoadjuvant intraperitoneal and systemic chemotherapy in gastric carcinoma with peritoneal metastasis.
Hao Y; Liu Y; Ishibashi H; Wakama S; Nishino E; Yonemura Y
Eur J Surg Oncol; 2019 Aug; 45(8):1493-1497. PubMed ID: 30948161
[TBL] [Abstract][Full Text] [Related]
17. Treatment of PERItoneal disease in Stomach Cancer with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy: PERISCOPE I initial results.
van der Kaaij RT; Wassenaar ECE; Koemans WJ; Sikorska K; Grootscholten C; Los M; Huitema A; Schellens JHM; Veenhof AAFA; Hartemink KJ; Aalbers AGJ; van Ramshorst B; Boerma D; Boot H; van Sandick JW
Br J Surg; 2020 Oct; 107(11):1520-1528. PubMed ID: 32277764
[TBL] [Abstract][Full Text] [Related]
18. Regional but fatal: Intraperitoneal metastasis in gastric cancer.
Wei J; Wu ND; Liu BR
World J Gastroenterol; 2016 Sep; 22(33):7478-85. PubMed ID: 27672270
[TBL] [Abstract][Full Text] [Related]
19. [Laparoscopic diagnosis of postoperative recurrence of peritoneal metastasis in gastric cancer patients and the clinical efficacy of bidirectional intraperitoneal and systemic chemotherapy].
Yan C; Yang ZY; Shi M; Xu W; Ni ZT; Hua ZC; Liu WT; Zhu ZL; Bi RD; Zheng YN; Feng RH; Yao XX; Chen MM; Li C; Zhang J; Yan M; Zhu ZG
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):492-498. PubMed ID: 32842430
[No Abstract] [Full Text] [Related]
20. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases.
Yang XJ; Li Y; al-shammaa Hassan AH; Yang GL; Liu SY; Lu YL; Zhang JW; Yonemura Y
Ann Surg Oncol; 2009 Feb; 16(2):345-51. PubMed ID: 19018599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
